Analysts expect Nutra Pharma Corp to report revenue of 7.06 M for 2017, against a range of 6.36 M to 7.76 M.
| Metric | 2017 | 2018 | 2019 |
|---|---|---|---|
| Reported (Actual) | - | - | |
| High Estimate | 7.76 M | 9.18 M | |
| Low Estimate | 6.36 M | 8.55 M | |
| Consensus Estimate | 7.06 M | 8.86 M |
Analysts expect Nutra Pharma Corp to report earnings per share of 0.00 for 2017, against a range of 0.00 to 0.00.
| Metric | 2017 | 2018 | 2019 |
|---|---|---|---|
| Reported (Actual) | - | - | |
| High Estimate | 0.00 | 0.03 | |
| Low Estimate | 0.00 | 0.03 | |
| Consensus Estimate | 0.00 | 0.03 |